Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
5.71
+0.15 (2.70%)
At close: Dec 18, 2025, 4:00 PM EST
5.66
-0.05 (-0.88%)
After-hours: Dec 18, 2025, 7:26 PM EST
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $191.73 million as of December 18, 2025. Its market cap has increased by 211.16% in one year.
Market Cap
191.73M
Enterprise Value
176.89M
1-Year Change
211.16%
Ranking
Category
Stock Price
$5.71
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $191.73M, an increase of 191.63%. That is a compound annual growth rate of 30.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 191.73M | 216.82% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |